GIPC1 and digestive system neoplasm: Patra et al. reported on the cell-permeable lipopeptide CR1166 that inhibits the PDZ domain of the GIPC (GAIP-interacting protein, C terminus) protein which is over expressed in breast and pancreas tumors (Patra et al., 2012).